Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women

Abstract Background Co-infection with hepatitis C virus (HCV) is common among HIV-infected women. Objective To further our understanding of the risk factors for HCV viremia and the predictors of HCV viral load among women. Study design We investigated sociodemographic, immunologic, and virologic fac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical virology 2008-04, Vol.41 (4), p.255-263
Hauptverfasser: Operskalski, Eva A, Mack, Wendy J, Strickler, Howard D, French, Audrey L, Augenbraun, Michael, Tien, Phyllis C, Villacres, Maria C, Spencer, LaShonda Y, DeGiacomo, Marina, Kovacs, Andrea
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Co-infection with hepatitis C virus (HCV) is common among HIV-infected women. Objective To further our understanding of the risk factors for HCV viremia and the predictors of HCV viral load among women. Study design We investigated sociodemographic, immunologic, and virologic factors associated with presence and level of HCV viremia among 1049 HCV-seropositive women, 882 of whom were HIV-infected and 167 HIV-uninfected at their entry into the Women's Interagency HIV Study. Results Plasma HCV RNA was detected in 852 (81%) of these 1049 women (range: 1.2–7.8 log10 copies/ml). HCV-viremic women were more likely to have an HIV RNA level >100,000 copies/ml ( P = 0.0004), to have reported smoking ( P = 0.01), or to be Black ( P = 0.005). They were less likely to have current or resolved hepatitis B infection. HCV RNA levels were higher in women who were >35 years old, or HIV-infected. Current smoking and history of drug use (crack/freebase cocaine, marijuana, amphetamines, or heroin) were each associated with both presence and level of viremia. Conclusions Substance abuse counseling aimed at eliminating ongoing use of illicit drugs and tobacco may reduce clinical progression, improve response to treatment, and decrease HCV transmission by lowering levels of HCV viremia in women.
ISSN:1386-6532
1873-5967
DOI:10.1016/j.jcv.2007.08.021